Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.68 USD | +0.16% | -0.71% | +4.28% |
05-08 | Vaxcyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-25 | Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.28% | 7.13B | |
+2.76% | 108B | |
+11.14% | 104B | |
+1.48% | 22.33B | |
-11.94% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.12% | 17.64B | |
+5.40% | 14.05B | |
+35.04% | 12.51B |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte Insider Sold Shares Worth $552,144, According to a Recent SEC Filing